Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics ...

In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from a science of prediction to one of design, why programmable drug ...

GV- and Arch-backed Pelage Pharma is developing a first-of-its-kind topical stem-cell therapy that could redefine the $10B ...

Nearly a year after expanding from single cell omics solutions into spatial biology, Takara Bio USA has launched a series of updates to its product portfolio designed to bring its new class of spatial ...

Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ova ...

Cervical cancer, one of the most preventable yet lethal malignancies among women, continues to threaten lives globally due to ...

Superintendent Anita Huggins praised the Charleston County Schools for their academic gains and historic achievements, ...

Superintendent Anita Huggins praised Charleston County Schools for their academic gains and historic achievements, ...

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the research results of the Phase Ib registrational ...

Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...

Cervical cancer remains a leading cause of preventable deaths among women, particularly in resource-limited rural areas.